The challenge of improving donor heart preservation

Heart Lung and Circulation

Volumn 13, Issue 1, 2004, Pages 74-83

  McCrystal, Graham D ^a   Pepe, Salvatore ^a   Esmore, Donald S ^a   Rosenfeldt, Franklin L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Donor Heart; Preservation solution; Transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CALCIUM ION; MAGNESIUM ION; POTASSIUM ION; PRESERVATION SOLUTION; REACTIVE OXYGEN METABOLITE; SODIUM ION;

ACTIN MYOSIN INTERACTION; BRAIN DEATH; CALCIUM TRANSPORT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART PRESERVATION; HEART TRANSPLANTATION; HOMEOSTASIS; HUMAN; NONHUMAN; ORGAN DONOR; PATIENT SELECTION; POTASSIUM TRANSPORT; PRESERVATION AND STORAGE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SODIUM TRANSPORT;

EID: 21344450784     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2004.01.027     Document Type: Review

References (78)

1. Kasper E, AS. Clinical evaluation of potential heart transplant recipients. In: Baumgartner R, Kasper, Theodore, editors. Heart and lung transplantation. Philadelphia: W.B. Saunders Company; 2002. p. 57-63.
2. Cattaneo S, GP. Mechanical circulatory assistance before heart transplantation. In: Baumgartner R, Kasper, Theodore, editors. Heart and lung transplantation. Philadelphia: W.B. Saunders Company; 2002. p. 120-32.
3. Conte J, FK, Baumgartner W. Evaluation and management of heart donors. In: Baumgartner R, Kasper, Theodore, editors. Heart and lung transplantation. Philadelphia: W.B. Saunders Company; 2002. p. 155-60.
4. Chen E, BH, Kendall S, van Trigt P. Hormonal and haemodynamic changes in a validated animal model of brain death. Crit Care Med 1996:24(8):1352-9.
5. Razek T, Olthoff K, Reilly PM. Issues in potential organ donor management. Surg Clin North Am 2000;80(3):1021-32.
6. Wilhelm MJ, Pratschke J, Beato F, Taal M, Kusaka M, Hancock WW, et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000; 102(19):2426-33.
7. Birks E, BP, Owen V, Latif N, Nyawo B, Yacoub M. Molecular and cellular mechanisms of donor heart dysfunction. Transplant Proc 2001;33:2749-51.
8. Ghosh S, MM, Kopp E. NF-Kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-60.
9. Epinat JC, GT. Diverse agents act at multiple levels to inhibit the rel/NF-Kappa B signal transduction pathway. Oncogene 1999;18:6896-909.
10. Liptay S, Bachem M, Hacker G, Adler G, Debatin KM, Schmid RM. Inhibition of nuclear factor kappa B and induction of apoptosis in T- lymphocytes by sulfasalazine. Br J Pharmacol 1999; 128(7):1361-9.
11. Nygaard CE, Townsend RN, Diamond DL. Organ donor management and organ outcome: a 6-year review from a Level I trauma center. J Trauma 1990;30(6):728-32.
12. Cooper DK, Novitzky D, Wicomb WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl 1989; 71(4):261-6.
13. Seguin C, Devaux Y, Grosjean S, Siaghy EM, Mairose P, Zannad F, et al. Evidence of functional myocardial ischemia associated with myocardial dysfunction in brain-dead pigs. Circulation 2001; 104(12 Suppl 1):I197-201.
14. Novitzky D, Cooper DK, Morrell D, Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988;45(1):32-6.
15. Nilsson B, Berggren H, Ekroth R, Mantovani V, Nilsson F, Svensson S, et al. Glucose-insulin-potassium (GIK) prevents derangement of myocardial metabolism in brain-dead pigs. Eur J Cardiothorac Surg 1994;8(8):442-6.
16. Oldfield GS, Commerford PJ, Opie LH. Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement. J Thorac Cardiovasc Surg 1986;91(6):874-8.
17. Wheeldon DR, Potter CD, Odura A, Wallwork J, Large SR. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995;14(4):734-42.
18. Buckberg GD. Update on current techniques of myocardial protection. Ann Thorac Surg 1995;60(3):805-14.
19. Mohara J, Tsutsumi H, Takeyoshi I, Tokumine M, Aizaki M, Ishikawa S, et al. The optimal pressure for initial flush with UW solution in heart procurement. J Heart Lung Transplant 2002; 21(3):383-90.
20. Jahania M, SJ, Narayan P, Lasley R, Mentzer R. Heart preservation for transplantation: principles and strategies. Ann Thorac Surg 1999;68:1983-7.
21. Depre C, Taegtmeyer H. Metabolic aspects of programmed cell survival and cell death in the heart. Cardiovasc Res 2000; 45(3):538-48.
22. von Oppell U, PS, Preiss P, Dunne T, Zilla P, Reichart B. Endothelial cell toxicity of solid-organ preservation solutions. Ann Thorac Surg 1990;50:902-10.
23. Wicomb WN, Collins GM. 24-h rabbit heart storage with UW solution. Effects of low-flow perfusion, colloid, and shelf storage. Transplantation 1989;48(1):6-9.
24. Wicomb W, Perey R, Portnoy V, Collins G. The transplantation and replacement of thoracic organs. The present status of biological and mechanical replacement of the heart and lungs. In: Cooper MLD, Patterson G, editors. Advances in heart storage, vol. 1. 2nd ed. Dordrecht: Kluwer Academic Publishers; 1996. p. 675-87.
25. Ganote C, Armstrong S. Ischaemia and the myocyte cytoskeleton: review and speculation. Cardiovasc Res 1993; 27(8):1387-403.
26. Wicomb WN, Perey R, Portnoy V, Collins GM. The role of reduced glutathione in heart preservation using a polyethylene glycol solution, Cardiosol. Transplantation 1992;54(1):181-2.
27. Piper HM, Garcia-Dorado D. Prime causes of rapid cardiomyocyte death during reperfusion. Ann Thorac Surg 1999; 68(5):1913-9.
28. Menasche P, PF, Grousset C, Peynet J, Mouas C, Bloch G, et al. Improved recovery of heart transplants with a specific kit of preservation solutions. J Thorac Cardiovasc Surg 1993; 105(2):353-63.
29. Kevelaitis E, OA, Peynet J, Mouas C, Menasche P. Preconditioning by mitochondrial ATP-sensitive potassium channel openers: an effective approach for improving the preservation of heart transplants. Circulation 1999;100(19 Supplement):II345-50.
30. Eigel BN, Hadley RW. Antisense inhibition of Na+/Ca2+ exchange during anoxia/reoxygenation in ventricular myocytes. Am J Physiol Heart Circ Physiol 2001;281(5):H2184-90.
31. Baxter K, HB, Jablonski P. Heart preservation with celsior solution improved by the addition of nitroglycerine. Transplantation 2001;71(10):1380-4.
32. Sommerschild H, KK. Pre-conditioning-endogenous defence mechanisms of the heart. Acta Anaesthesiol Sacand 2002; 46:123-37.
33. Fox C, Ramsoomair D, Carter C. Magnesium: its proven and potential clinical significance. South Med J 2001; 94(12):1195-201.
34. Flink EB, Brick JE, Shane SR. Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction. Arch Intern Med 1981;141(4):441-3.
35. Whang R, Whang DD, Ryan MP. Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 1992; 152(1):40-5.
36. Siegmund B, Zude R, Piper HM. Recovery of anoxic-reoxygenated cardiomyocytes from severe Ca2+ overload.Am J Physiol 1992; 263(4 Pt 2):H1262-9.
37. Karmazyn M, Gan XT, Humphreys RA, Yoshida H, Kusumoto K. The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease. Circ Res 1999;85(9):777-86.
38. Hoenicke EM, Peterseim DS, Ducko CT, Sun X, Damiano RJ. Donor heart preservation with the potassium channel opener pinacidil: comparison with University of Wisconsin and St. Thomas' solution. J Heart Lung Transplant 2000;19(3):286-97.
39. Gross GJ, Kersten JR, Warltier DC. Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg 1999; 68(5):1898-904.
40. Siegmund B, Ladilov YV, Piper HM. Importance of sodium for recovery of calcium control in reoxygenated cardiomyocytes. Am J Physiol 1994;267(2 Pt 2):H506-13.
41. Lakatta EG, Sollott SJ, Pepe S. The old heart: operating on the edge. Novartis Found Symp 2001;235:172-96.
42. Bulger EM, Maier RV. Antioxidants in critical illness. Arch Surg 2001;136(10):1201-7.
43. Amrani M, Mankad PS, Yacoub MH. Improved preservation of endothelial function at 4 °C. Eur J Cardiothorac Surg 1992; 6(2):72-8.
44. Mankad P, CA, Yacoub M. Role of potassium concentration in cardioplegic solutions in mediating endothelial damage. Ann Thorac Surg 1991;51:89-93.
45. Saldanha C, Hearse DJ. Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. Possible evidence of endothelial damage. J Thorac Cardiovasc Surg 1989;98(5 Pt 1):783-7.
46. Saitoh Y, HM, Ku K, Kin S, Nosaka S, Musumura S, et al. Heart preservation in HTK solution. Role of coronary vasculature in recovery of cardiac function. Ann Thorac Surg 2000;69:107-2.
47. Ou R, GJ, Esmore D, Rosenfeldt F. Increased temperature reduces the protective effect of university of Wisconsin Solution in the heart. Ann Thorac Surg 1999;68:1628-35.
48. Xiao XH, Allen DG. Activity of the Na(+)/H(+) exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart. Cardiovasc Res 2000;48(2):244-53.
49. Hendry P, LR, Keon W. A comparison of intracellular solutions for donor heart preservation. J Thorac Cardiovasc Surg 1993; 105(4):667-73.
50. Kresh J, NC, Bianchi C, Goldman S, Brockman S. The relative buffering power of cardioplegic solutions. J Thorac Cardiovasc Surg 1987;93(2):309-11.
51. Southard J, BF. Organ preservation. Annu Rev Med 1995;46:235-47.
52. Wolkowicz PE, Caulfield JB. Cardioplegia with aged UW solution induces loss of cardiac collagen. Transplantation 1991; 51(4):898-901.
53. Gumina R, BE, Daemmgen J, Gross G. Direct comparison of the cardioprotective efficacy of ischaemic preconditioning and Na+/H+ exchange inhibition. Circulation 1998;Supplement I(98):I-344.
54. Kevelaitis E, OA, Mouas C, Peynet J, Menasche P. Ischaemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na?h exchange inhibition: which is the best protective strategy for heart transplants? J Thorac Cardiovasc Surg 2001;121(1):155-62.
55. Menasche P, TJ, Pradier F, Grousset C, Mouas C, Alberici, et al. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg 1994;8:207-13.
56. Ferrera R, Michel P, Hadour G, Rodriguez C, Ovize M, Phan Tan Luu R. An optimal experimental design for the development of preservative heart solutions. J Heart Lung Transplant 2002;21(2):260-70.
57. Choong YS, Gavin JB, Armiger LC. Effects of glutamic acid on cardiac function and energy metabolism of rat heart during ischaemia and reperfusion. J Mol Cell Cardiol 1988;20(11):1043-51.
58. Haan CK, Lazar HL, Rivers S, Coady C, Shemin RJ. Improved myocardial preservation during cold storage using substrate enhancement. Ann Thorac Surg 1990;50(1):80-5.
59. Kjellman UW, Bjork K, Ekroth R, Karlsson H, Jagenburg R, Nilsson FN, et al. Addition of alpha-ketoglutarate to blood cardioplegia improves cardioprotection. Ann Thorac Surg 1997; 63(6):1625-33.[discussion 1634]
60. Lasley RD, Mentzer RM. The role of adenosine in extended myocardial preservation with the University of Wisconsin solution. J Thorac Cardiovasc Surg 1994;107(5):1356-63.
61. Garcia-Dorado D, Theroux P, Duran JM, Solares J, Alonso J, Sanz E, et al. Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 1992;85(3):1160-74.
62. Warnecke G, Schulze B, Hagl C, Haverich A, Klima U. Improved right heart function after myocardial preservation with 2,3-butanedione 2-monoxime in a porcine model of allogenic heart transplantation. J Thorac Cardiovasc Surg 2002;123(1):81-8.
63. Siegmund B, KT, Schwartz P, Piper H. Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. Am J Physiol Heart Circ Physiol 1991;260(29):H426-35.
64. Ladilov Y, Haffner S, Balser-Schafer C, Maxeiner H, Piper HM. Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na+/Ca2+ exchanger. Am J Physiol 1999;276(6 Pt 2):H1868-76.
65. Sbarikabad MN, Ostbye KM, Brors O. Increased [Mg2+]o reduces Ca2+ influx and disruption of mitochondrial membrane potential during reoxygenation. Am J Physiol Heart Circ Physiol 2001; 281(5):H2113-23.
66. McLean RM. Magnesium and its therapeutic uses: a review. Am J Med 1994;96(1):63-76.
67. Schwalb H, GL, Yaroslavsky-Houminer E, Lazarovici G, Van Oppell U, Worthington M, et al. New solution for prolonged myocardial preservation for transplantation. J Heart Lung Transplant 1998; 17(2):222-9.
68. Nickless DK, Rabinov M, Richards SM, Conyers RA, Rosenfeldt FL. Continuous perfusion improves preservation of donor rat hearts: importance of the implantation phase. Ann Thorac Surg 1998; 65(5):1265-72.
69. Okada K, Yamashita C, Okada M. Successful 24-h rabbit heart preservation by hypothermic continuous coronary microperfusion with oxygenated University of Wisconsin Solution. Ann Thorac Surg 1995;60(6):1723-8.
70. Daily PO, Adamson RM, Jones BH, Dembitsky WP, Moreno-Cabral RJ. Comparisons of methods of myocardial hypothermia for cardiac transplantation. Ann Thorac Surg 1996;61(2):679-83.
71. Carrier M, Leung TK, Solymoss BC, Cartier R, Leclerc Y, Pelletier LC. Clinical trial of retrograde warm blood reperfusion versus standard cold topical irrigation of transplanted hearts. Ann Thorac Surg 1996;61(5):1310-4.[discussion 1314-5]
72. Sawa Y, TK, Kadoba K, Nishimura M, Ichikawa H, Amemiya A, et al. Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation 1996; 93(9):1640-6.
73. Hurst T, JD, Cujec B, Thomson D, Mycyk T, Burbridge B, et al. Depletion of activated neutrophils by a filter during cardiac valve surgery. Can J Anaesth 1997;44(2):131-9.
74. Sawa Y, MH, Shimazaki T, Kaneko M, Nishimura M, Amemiya A, et al. Evaluation of leukocyte depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;108(6):1125-31.
75. Pearl J, Drinkwater DC, Laks H, Capouya ER, Gates RN. Leukocyte depleted reperfusion of transplanted human hearts: a randomised, double blind clinical trial. J Heart Lung Transplant 1992;11:1082-92.
76. Pearl JDD, Laks H, Stein DG, Capouya ER, Bhuta S. Leukocyte depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res 1992a; 52:295-308.
77. Rosenfeldt F, McCrystal G, Pepe S, Esmore D. Myocyte or heart preservation? In: Large S, editor. ISHLT Fall Meeting; 2002.
78. Zaroff JG, Rosengard B, Armstrong WE, Babcock WD, D'Alessandro A, Dec GW, et al. Maximising use of organs recovered from the cadaver donor: cardiac recommendations. (Consensus Conference Report, March 28-29, 2001, Crystal City). J Heart Lung Transplant 2002; 21(11):1153-60.